Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $260.57 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $153.46 | 9 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $41.05 | 2 | $0 (2017) |
| Merck Sharp & Dohme LLC | $24.44 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $22.00 | 1 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $19.62 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.44 | 1 | Merck Sharp & Dohme LLC ($24.44) |
| 2023 | $38.67 | 2 | GlaxoSmithKline, LLC. ($22.00) |
| 2022 | $22.41 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($22.41) |
| 2021 | $37.20 | 2 | E.R. Squibb & Sons, L.L.C. ($19.62) |
| 2019 | $62.04 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($62.04) |
| 2018 | $18.75 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($18.75) |
| 2017 | $57.06 | 3 | Janssen Pharmaceuticals, Inc ($41.05) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: VACCINE | ||||||
| 11/29/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.67 | General |
| 09/18/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: RESPIRATORY | ||||||
| 02/23/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $22.41 | General |
| Category: DIABETES | ||||||
| 11/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: DIABETES | ||||||
| 11/03/2021 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $19.62 | General |
| Category: Cardiovascular | ||||||
| 09/06/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.29 | General |
| Category: DIABETES | ||||||
| 07/31/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $12.54 | General |
| Category: DIABETES | ||||||
| 05/15/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $12.86 | General |
| Category: DIABETES | ||||||
| 04/11/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $24.35 | General |
| Category: DIABETES | ||||||
| 04/04/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: DIABETES | ||||||
| 04/26/2017 | Janssen Pharmaceuticals, Inc | ZYTIGA (Drug), SIMPONI, PREZISTA | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Oncology | ||||||
| 03/01/2017 | Janssen Pharmaceuticals, Inc | PREZCOBIX (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 02/15/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 752 | 756 | $25,704 | $21,699 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 315 | 317 | $13,501 | $11,840 | 87.7% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 313 | 315 | $8,004 | $5,799 | 72.4% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 61 | 61 | $2,598 | $2,460 | 94.7% |
| 0011A | Adm sarscov2 100mcg/0.5ml1st | Office | 2021 | 63 | 63 | $1,601 | $1,601 | 100.0% |
About Dr. Norma Rivera, M.D
Dr. Norma Rivera, M.D is a Family Medicine healthcare provider based in San Sebastian, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205973310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Norma Rivera, M.D has received a total of $260.57 in payments from pharmaceutical and medical device companies, with $24.44 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($260.57).
As a Medicare-enrolled provider, Rivera has provided services to 752 Medicare beneficiaries, totaling 756 services with total Medicare billing of $21,699. Data is available for 1 year (2021–2021), covering 4 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location San Sebastian, PR
- Active Since 01/30/2007
- Last Updated 07/08/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1205973310
Products in Payments
- JARDIANCE (Drug) $80.83
- TRADJENTA (Drug) $55.96
- GARDASIL (Biological) $24.44
- PREZCOBIX (Drug) $23.27
- AREXVY (Drug) $22.00
- ELIQUIS (Drug) $19.62
- ZYTIGA (Drug) $17.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.